NearWave
ActiveHelping physicians select the right therapy for breast cancer patients
About
NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.
Founders · 1
Roy Stillwell is the co-founder, CEO and chief engineer of NearWave, which he co-founded with Professor Thomas O'Sullivan in 2020. He has a PhD in electrical engineering, with a focus in biophotonics research. Originally from Colorado, Roy is a father, husband, technologist, gamer, boarder, and loves to build.
Launch
NearWave makes a new type of handheld imaging tech with AI that helps physicians select the right therapy for their breast cancer patients.
NearWave builds an imaging system and AI models using fdNIRS to predict breast cancer treatment response within days, enabling oncologists to adjust or change neoadjuvant chemotherapy early. The product targets physicians treating invasive breast cancer, aiming to reduce unnecessary side effects and costs by identifying non-responders quickly.
From the original launch (May 2024) — may be outdated.
Related startups
Tele-dermatology for chronic skin conditions
High-precision, closed-loop neuromodulation devices
